MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$20,915K
Unrealized gain related to
available for sale...
$106K
Gene Dx
$415,641K
All Other Segments
$1,027K
Gene Dx
$7,447K
All Other Segments
$3,424K
Net loss
-$21,021K
Income tax benefit
-$116K
Diagnostic Test
$416,668K
Product And Service
Other
$10,871K
Loss before income
taxes
-$21,137K
Total revenue
$427,539K
Loss from operations
-$13,077K
Total non-operating
(expense) income, net
-$8,060K
Gross profit
$298,173K
Cost of services
$129,366K
General and
administrative
$150,819K
Other (expense)
income, net
-$4,317K
Interest (expense)
income, net
-$2,539K
Change in fair value of
financial liabilities
-$1,204K
Selling and marketing
$88,405K
Research and development
$72,026K
Back
Back
Income Statement
source: myfinsight.com
GeneDx Holdings Corp. (WGSWW)
GeneDx Holdings Corp. (WGSWW)